Works matching IS 08876924 AND DT 2013 AND VI 27 AND IP 2

Results: 40

γ-Catenin is overexpressed in acute myeloid leukemia and promotes the stabilization and nuclear localization of β-catenin.

Published in:

2013

By:

Morgan RG;
Pearn L;
Liddiard K;
Pumford SL;
Burnett AK;
Tonks A;
Darley RL;
Morgan, R G;
Pearn, L;
Liddiard, K;
Pumford, S L;
Burnett, A K;
Tonks, A;
Darley, R L

Publication type:

journal article

Immunosuppressive CD14(+)HLA-DR(low/neg) IDO(+) myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.

Published in:

2013

By:

Mougiakakos D;
Jitschin R;
von Bahr L;
Poschke I;
Gary R;
Sundberg B;
Gerbitz A;
Ljungman P;
Le Blanc K

Publication type:

Journal Article

Call for case histories of BMT in patients with coincident schizophrenia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 1, doi. 10.1038/leu.2013.32

By:

Sommer, I. E.;
van Bekkum, D. W.

Publication type:

Article

E Donnall Thomas (1920-2012).

Published in:

2013

By:

Peter Gale, Robert

Publication type:

Obituary

The short form of RON is expressed in acute myeloid leukemia and sensitizes leukemic cells to cMET inhibitors.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 325, doi. 10.1038/leu.2012.240

By:

Fialin, C;
Larrue, C;
Vergez, F;
Sarry, J E;
Bertoli, S;
Mansat-De Mas, V;
Demur, C;
Delabesse, E;
Payrastre, B;
Manenti, S;
Roche, S;
Récher, C

Publication type:

Article

NPM1 mutations occur rarely or not at all in chronic myeloid leukaemia patients in chronic phase or blast crisis.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 489, doi. 10.1038/leu.2012.193

By:

Watkins, D B;
Hughes, T P;
White, D L;
D'Andrea, R J

Publication type:

Article

Transcriptional suppression of BACH2 by the Bcr-Abl oncoprotein is mediated by PAX5.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 409, doi. 10.1038/leu.2012.220

By:

Casolari, D A;
Makri, M;
Yoshida, C;
Muto, A;
Igarashi, K;
Melo, J V

Publication type:

Article

Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 503, doi. 10.1038/leu.2012.204

By:

Dupuis, A;
Gaub, M P;
Legrain, M;
Drenou, B;
Mauvieux, L;
Lutz, P;
Herbrecht, R;
Chan, S;
Kastner, P

Publication type:

Article

Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 416, doi. 10.1038/leu.2012.205

By:

Mussolin, L;
Damm-Welk, C;
Pillon, M;
Zimmermann, M;
Franceschetto, G;
Pulford, K;
Reiter, A;
Rosolen, A;
Woessmann, W

Publication type:

Article

γ-Catenin is overexpressed in acute myeloid leukemia and promotes the stabilization and nuclear localization of β-catenin.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 336, doi. 10.1038/leu.2012.221

By:

Morgan, R G;
Pearn, L;
Liddiard, K;
Pumford, S L;
Burnett, A K;
Tonks, A;
Darley, R L

Publication type:

Article

Single-nucleotide polymorphism rs1052501 associated with monoclonal gammopathy of undetermined significance and multiple myeloma.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 515, doi. 10.1038/leu.2012.232

By:

Greenberg, A J;
Lee, A M;
Serie, D J;
McDonnell, S K;
Cerhan, J R;
Liebow, M;
Larson, D R;
Colby, C L;
Norman, A D;
Kyle, R A;
Kumar, S;
Rajkumar, S V;
Diasio, R B;
Slager, S L;
Vachon, C M

Publication type:

Article

The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 507, doi. 10.1038/leu.2012.209

By:

Matutes, E;
Bosanquet, A G;
Wade, R;
Richards, S M;
Else, M;
Catovsky, D

Publication type:

Article

Targeting the KIT activating switch control pocket: a novel mechanism to inhibit neoplastic mast cell proliferation and mast cell activation.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 278, doi. 10.1038/leu.2012.218

By:

Bai, Y;
Bandara, G;
Ching Chan, E;
Maric, I;
Simakova, O;
Bandara, S N;
Lu, W-P;
Wise, S C;
Flynn, D L;
Metcalfe, D D;
Gilfillan, A M;
Wilson, T M

Publication type:

Article

Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 370, doi. 10.1038/leu.2012.234

By:

Garand, R;
Beldjord, K;
Cavé, H;
Fossat, C;
Arnoux, I;
Asnafi, V;
Bertrand, Y;
Boulland, M-L;
Brouzes, C;
Clappier, E;
Delabesse, E;
Fest, T;
Garnache-Ottou, F;
Huguet, F;
Jacob, M-C;
Kuhlein, E;
Marty-Grès, S;
Plesa, A;
Robillard, N;
Roussel, M

Publication type:

Article

Suppression of the let-7b microRNA pathway by DNA hypermethylation in infant acute lymphoblastic leukemia with MLL gene rearrangements.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 389, doi. 10.1038/leu.2012.242

By:

Nishi, M;
Eguchi-Ishimae, M;
Wu, Z;
Gao, W;
Iwabuki, H;
Kawakami, S;
Tauchi, H;
Inukai, T;
Sugita, K;
Hamasaki, Y;
Ishii, E;
Eguchi, M

Publication type:

Article

Role and potential for therapeutic targeting of MYB in leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 269, doi. 10.1038/leu.2012.225

By:

Pattabiraman, D R;
Gonda, T J

Publication type:

Article

Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 315, doi. 10.1038/leu.2012.180

By:

Wang, R;
Xia, L;
Gabrilove, J;
Waxman, S;
Jing, Y

Publication type:

Article

The feed-forward loop between YB-1 and MYC is essential for multiple myeloma cell survival.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 441, doi. 10.1038/leu.2012.185

By:

Bommert, K S;
Effenberger, M;
Leich, E;
Küspert, M;
Murphy, D;
Langer, C;
Moll, R;
Janz, S;
Mottok, A;
Weissbach, S;
Rosenwald, A;
Bargou, R;
Bommert, K

Publication type:

Article

Partial 17q gain resulting from isochromosomes, unbalanced translocations and complex rearrangements is associated with gene overexpression, older age and shorter overall survival in high hyperdiploid childhood acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 493, doi. 10.1038/leu.2012.198

By:

Herou, E;
Biloglav, A;
Johansson, B;
Paulsson, K

Publication type:

Article

Whole-genome-amplified DNA as a source for mutational analysis underestimates the frequency of mutations in pediatric acute myeloid leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 510, doi. 10.1038/leu.2012.250

By:

Rosenquist, R;
Ehrencrona, H;
Hasle, H;
Palle, J;
Kanduri, M

Publication type:

Article

Marrow stromal cells induce B7-H1 expression on myeloma cells, generating aggressive characteristics in multiple myeloma.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 464, doi. 10.1038/leu.2012.213

By:

Tamura, H;
Ishibashi, M;
Yamashita, T;
Tanosaki, S;
Okuyama, N;
Kondo, A;
Hyodo, H;
Shinya, E;
Takahashi, H;
Dong, H;
Tamada, K;
Chen, L;
Dan, K;
Ogata, K

Publication type:

Article

Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 353, doi. 10.1038/leu.2012.208

By:

Rücker, F G;
Russ, A C;
Cocciardi, S;
Kett, H;
Schlenk, R F;
Botzenhardt, U;
Langer, C;
Krauter, J;
Fröhling, S;
Schlegelberger, B;
Ganser, A;
Lichter, P;
Zenz, T;
Döhner, H;
Döhner, K;
Bullinger, L

Publication type:

Article

Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 451, doi. 10.1038/leu.2012.190

By:

Bolzoni, M;
Donofrio, G;
Storti, P;
Guasco, D;
Toscani, D;
Lazzaretti, M;
Bonomini, S;
Agnelli, L;
Capocefalo, A;
Dalla Palma, B;
Neri, A;
Nicolini, F;
Lisignoli, G;
Russo, F;
Colla, S;
Aversa, F;
Giuliani, N

Publication type:

Article

The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 423, doi. 10.1038/leu.2012.182

By:

Dimopoulos, M A;
Roussou, M;
Gkotzamanidou, M;
Nikitas, N;
Psimenou, E;
Mparmparoussi, D;
Matsouka, C;
Spyropoulou-Vlachou, M;
Terpos, E;
Kastritis, E

Publication type:

Article

miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 344, doi. 10.1038/leu.2012.224

By:

Lin, X;
Rice, K L;
Buzzai, M;
Hexner, E;
Costa, F F;
Kilpivaara, O;
Mullally, A;
Soares, M B;
Ebert, B L;
Levine, R;
Licht, J D

Publication type:

Article

FLT3 inhibition: a moving and evolving target in acute myeloid leukaemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 260, doi. 10.1038/leu.2012.195

By:

Leung, A Y H;
Man, C-H;
Kwong, Y-L

Publication type:

Article

Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 286, doi. 10.1038/leu.2012.203

By:

Kanda, J;
Ichinohe, T;
Kato, S;
Uchida, N;
Terakura, S;
Fukuda, T;
Hidaka, M;
Ueda, Y;
Kondo, T;
Taniguchi, S;
Takahashi, S;
Nagamura-Inoue, T;
Tanaka, J;
Atsuta, Y;
Miyamura, K;
Kanda, Y

Publication type:

Article

Telomeres and chromosomal instability in chronic lymphocytic leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 490, doi. 10.1038/leu.2012.194

By:

Véronèse, L;
Tournilhac, O;
Callanan, M;
Prie, N;
Kwiatkowski, F;
Combes, P;
Chauvet, M;
Davi, F;
Gouas, L;
Verrelle, P;
Guièze, R;
Vago, P;
Bay, J O;
Tchirkov, A

Publication type:

Article

Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 362, doi. 10.1038/leu.2012.228

By:

Brown, J R;
Kim, H T;
Armand, P;
Cutler, C;
Fisher, D C;
Ho, V;
Koreth, J;
Ritz, J;
Wu, C;
Antin, J H;
Soiffer, R J;
Gribben, J G;
Alyea, E P

Publication type:

Article

Glucocorticoid sensitivity of T-cell lymphoblastic leukemia/lymphoma is associated with glucocorticoid receptor-mediated inhibition of Notch1 expression.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 485, doi. 10.1038/leu.2012.192

By:

Cialfi, S;
Palermo, R;
Manca, S;
Checquolo, S;
Bellavia, D;
Pelullo, M;
Quaranta, R;
Dominici, C;
Gulino, A;
Screpanti, I;
Talora, C

Publication type:

Article

NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 512, doi. 10.1038/leu.2012.307

By:

Mansouri, L;
Cahill, N;
Gunnarsson, R;
Smedby, K E;
Tjönnfjord, E;
Hjalgrim, H;
Juliusson, G;
Geisler, C;
Rosenquist, R

Publication type:

Article

Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 377, doi. 10.1038/leu.2012.215

By:

Mougiakakos, D;
Jitschin, R;
von Bahr, L;
Poschke, I;
Gary, R;
Sundberg, B;
Gerbitz, A;
Ljungman, P;
Le Blanc, K

Publication type:

Article

Minor clone provides a reservoir for relapse in multiple myeloma.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 473, doi. 10.1038/leu.2012.226

By:

Magrangeas, F;
Avet-Loiseau, H;
Gouraud, W;
Lodé, L;
Decaux, O;
Godmer, P;
Garderet, L;
Voillat, L;
Facon, T;
Stoppa, A M;
Marit, G;
Hulin, C;
Casassus, P;
Tiab, M;
Voog, E;
Randriamalala, E;
Anderson, K C;
Moreau, P;
Munshi, N C;
Minvielle, S

Publication type:

Article

The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 430, doi. 10.1038/leu.2012.183

By:

Hurchla, M A;
Garcia-Gomez, A;
Hornick, M C;
Ocio, E M;
Li, A;
Blanco, J F;
Collins, L;
Kirk, C J;
Piwnica-Worms, D;
Vij, R;
Tomasson, M H;
Pandiella, A;
San Miguel, J F;
Garayoa, M;
Weilbaecher, K N

Publication type:

Article

The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivo.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 398, doi. 10.1038/leu.2012.308

By:

Nabinger, S C;
Li, X J;
Ramdas, B;
He, Y;
Zhang, X;
Zeng, L;
Richine, B;
Bowling, J D;
Fukuda, S;
Goenka, S;
Liu, Z;
Feng, G-S;
Yu, M;
Sandusky, G E;
Boswell, H S;
Zhang, Z-Y;
Kapur, R;
Chan, R J

Publication type:

Article

Receptor kinase profiles identify a rationale for multitarget kinase inhibition in immature T-ALL.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 305, doi. 10.1038/leu.2012.177

By:

Lhermitte, L;
Ben Abdelali, R;
Villarèse, P;
Bedjaoui, N;
Guillemot, V;
Trinquand, A;
Libura, M;
Bedin, A S;
Petit, A;
Dombret, H;
Leverger, G;
Ifrah, N;
Hermine, O;
Macintyre, E;
Asnafi, V

Publication type:

Article

Molecular mutations are prognostically relevant in AML with intermediate risk cytogenetics and aberrant karyotype.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 496, doi. 10.1038/leu.2012.200

By:

Bacher, U;
Haferlach, T;
Alpermann, T;
Kern, W;
Schnittger, S;
Haferlach, C

Publication type:

Article

Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 295, doi. 10.1038/leu.2012.155

By:

Krentz, S;
Hof, J;
Mendioroz, A;
Vaggopoulou, R;
Dörge, P;
Lottaz, C;
Engelmann, J C;
Groeneveld, T W L;
Körner, G;
Seeger, K;
Hagemeier, C;
Henze, G;
Eckert, C;
von Stackelberg, A;
Kirschner-Schwabe, R

Publication type:

Article

GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 482, doi. 10.1038/leu.2012.174

By:

Fasan, A;
Eder, C;
Haferlach, C;
Grossmann, V;
Kohlmann, A;
Dicker, F;
Kern, W;
Haferlach, T;
Schnittger, S

Publication type:

Article

Encapsulated mesenchymal stem cells for in vivo immunomodulation.

Published in:

Leukemia (08876924), 2013, v. 27, n. 2, p. 500, doi. 10.1038/leu.2012.202

By:

Zanotti, L;
Sarukhan, A;
Dander, E;
Castor, M;
Cibella, J;
Soldani, C;
Trovato, A E;
Ploia, C;
Luca, G;
Calvitti, M;
Mancuso, F;
Arato, I;
Golemac, M;
Jonjic, N;
Biondi, A;
Calafiore, R;
Locati, M;
D'Amico, G;
Viola, A

Publication type:

Article